TWI327910B - - Google Patents

Download PDF

Info

Publication number
TWI327910B
TWI327910B TW093107492A TW93107492A TWI327910B TW I327910 B TWI327910 B TW I327910B TW 093107492 A TW093107492 A TW 093107492A TW 93107492 A TW93107492 A TW 93107492A TW I327910 B TWI327910 B TW I327910B
Authority
TW
Taiwan
Prior art keywords
solution
pharmaceutical composition
argatroban
group
ethanol
Prior art date
Application number
TW093107492A
Other languages
English (en)
Chinese (zh)
Other versions
TW200505422A (en
Inventor
Kazuhiko Ozaki
Manami Hiramiya
Katsuyoshi Yoshizawa
Takashi Yamada
Takeshi Hirokawa
Kouichi Sugawara
Katsunori Kurusu
Noboru Yamada
Kenichi Kajihara
Original Assignee
Mitsubishi Tanabe Pharma Corp
Towa Pharma Ceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33027937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI327910(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mitsubishi Tanabe Pharma Corp, Towa Pharma Ceutical Co Ltd filed Critical Mitsubishi Tanabe Pharma Corp
Publication of TW200505422A publication Critical patent/TW200505422A/zh
Application granted granted Critical
Publication of TWI327910B publication Critical patent/TWI327910B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW093107492A 2003-03-20 2004-03-19 Pharmaceutical preparations containing arginine amides TW200505422A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003077125 2003-03-20

Publications (2)

Publication Number Publication Date
TW200505422A TW200505422A (en) 2005-02-16
TWI327910B true TWI327910B (es) 2010-08-01

Family

ID=33027937

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093107492A TW200505422A (en) 2003-03-20 2004-03-19 Pharmaceutical preparations containing arginine amides

Country Status (5)

Country Link
JP (1) JP3781308B2 (es)
KR (1) KR101010547B1 (es)
CN (1) CN100344624C (es)
TW (1) TW200505422A (es)
WO (1) WO2004083201A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006008696A (ja) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp アルギニンアミド類を含有する医薬製剤
MX2008002177A (es) * 2005-09-01 2008-04-22 Baxter Healthcare Sa Formulacion de argatroban.
JP5438999B2 (ja) * 2009-03-19 2014-03-12 テルモ株式会社 アルガトロバン注射液製剤
CN102120026A (zh) * 2011-03-03 2011-07-13 天津市炜杰科技有限公司 以醇作为增溶剂的21(s)阿加曲班静脉注射液
CN102228426A (zh) * 2011-06-17 2011-11-02 天津市炜杰科技有限公司 以醇作为增溶剂的21(r)阿加曲班静脉注射液
CN104098647B (zh) * 2014-06-24 2017-12-08 安徽省逸欣铭医药科技有限公司 阿加曲班类似物及其制备方法和医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
US5214052A (en) * 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
JP3530542B2 (ja) * 1992-03-18 2004-05-24 三菱化学株式会社 眼科用アルガトロバン製剤
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
JP2002241284A (ja) * 2001-02-16 2002-08-28 Towa Yakuhin Kk 全身投与用アルガトロバン注射液

Also Published As

Publication number Publication date
KR101010547B1 (ko) 2011-01-24
WO2004083201A1 (ja) 2004-09-30
JPWO2004083201A1 (ja) 2006-06-22
KR20060002825A (ko) 2006-01-09
TW200505422A (en) 2005-02-16
JP3781308B2 (ja) 2006-05-31
CN100344624C (zh) 2007-10-24
CN1761661A (zh) 2006-04-19

Similar Documents

Publication Publication Date Title
KR102708440B1 (ko) 신규한 조성물 및 방법
WO1999002158A1 (fr) Compositions medicinales stables, contenant des derives de 4,5-epoxymorphinane
CN104470499A (zh) 可注射制剂
AU2016385362A1 (en) Long acting injectable formulations
JP6356873B2 (ja) タキサン系活性成分含有液体組成物及び液体製剤
TW202128210A (zh) 欣得泰乾粉注射劑穩定劑型
TWI327910B (es)
TW200418477A (en) Depot formulations in the form of a suspension
WO2018177232A1 (zh) 难溶性复合物或其溶剂合物、药物组合物及其应用
KR101770808B1 (ko) 이부프로펜의 주사용 약제학적 조성물
WO2007009355A1 (fr) Injection de paclitaxel et sa méthode de préparation
US9616128B2 (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
CA2669727C (en) Alcohol free formulation of argatroban
JPH0576929B2 (es)
JP4607761B2 (ja) 溶液医薬組成物
CN102302495A (zh) 一种供注射用盐酸托烷司琼药物组合物
JP2006008696A (ja) アルギニンアミド類を含有する医薬製剤
WO2008045410A2 (en) Alcohol free formulation of argatroban
US20130023559A1 (en) Alcohol free formulation of argatroban
JP2016216504A (ja) ドセタキセル製剤
WO2023178039A1 (en) Pharmaceutical formulations of r-ketamine
TW202430147A (zh) 包含高濃度奧匹蘭色林的醫藥組成物
WO2023108156A1 (en) Ziprasidone formulations
CN115381927A (zh) 一种用于治疗缺血性脑梗塞的药物预灌装注射剂
KR20240074687A (ko) 고농도의 오피란제린을 포함하는 약제학적 조성물

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees